Zhou J - Search Results

1

Epigenetic and immunohistochemical characterization of the Clusterin gene in ovarian tumors.

Yang G, Zhang H, Liu Y, Zhou J, He W, Quick CM, Xie D, Smoller BR, Fan CY. Yang G, et al. Among authors: zhou j. Arch Gynecol Obstet. 2013 May;287(5):989-95. doi: 10.1007/s00404-012-2650-6. Epub 2012 Dec 4. Arch Gynecol Obstet. 2013. PMID: 23208459

2

CHD1L protein is overexpressed in human ovarian carcinomas and is a novel predictive biomarker for patients survival.

He WP, Zhou J, Cai MY, Xiao XS, Liao YJ, Kung HF, Guan XY, Xie D, Yang GF. He WP, et al. Among authors: zhou j. BMC Cancer. 2012 Sep 29;12:437. doi: 10.1186/1471-2407-12-437. BMC Cancer. 2012. PMID: 23020525 Free PMC article.

3

The prognostic value of histologic subtype in node-positive early-stage cervical cancer after hysterectomy and adjuvant radiotherapy.

Zhou J, Zhang WW, Wu SG, He ZY, Sun JY, Yang GF, Li FY. Zhou J, et al. Int J Surg. 2017 Aug;44:1-6. doi: 10.1016/j.ijsu.2017.05.074. Epub 2017 Jun 2. Int J Surg. 2017. PMID: 28583891 Free article.

4

The effect of lymphadenectomy in advanced ovarian cancer according to residual tumor status: A population-based study.

Zhou J, Zhang WW, Zhang QH, He ZY, Sun JY, Chen QH, Wu SG. Zhou J, et al. Int J Surg. 2018 Apr;52:11-15. doi: 10.1016/j.ijsu.2018.02.006. Epub 2018 Feb 9. Int J Surg. 2018. PMID: 29432972 Free article.

5

Prognostic value of lymph node ratio in stage IIIC epithelial ovarian cancer with node-positive in a SEER population-based study.

Zhou J, He ZY, Li FY, Sun JY, Lin HX, Wu SG, Chen QH. Zhou J, et al. Oncotarget. 2016 Feb 16;7(7):7952-9. doi: 10.18632/oncotarget.6911. Oncotarget. 2016. PMID: 26788911 Free PMC article.

6

The local treatment modalities in FIGO stage I-II small-cell carcinoma of the cervix are determined by disease stage and lymph node status.

Zhou J, Yang HY, Wu SG, He ZY, Lin HX, Sun JY, Li Q, Guo ZW. Zhou J, et al. Cancer Med. 2016 Jun;5(6):1108-15. doi: 10.1002/cam4.687. Epub 2016 Mar 14. Cancer Med. 2016. PMID: 26990881 Free PMC article.

7

Risk factors for lymph node metastasis in ovarian cancer: Implications for systematic lymphadenectomy.

Zhou J, Sun JY, Wu SG, Wang X, He ZY, Chen QH, Li FY. Zhou J, et al. Int J Surg. 2016 May;29:123-7. doi: 10.1016/j.ijsu.2016.03.039. Epub 2016 Mar 19. Int J Surg. 2016. PMID: 27000718 Free article.

8

Clinicopathological features of small cell carcinoma of the uterine cervix in the surveillance, epidemiology, and end results database.

Zhou J, Wu SG, Sun JY, Tang LY, Lin HX, Li FY, Chen QH, Jin X, He ZY. Zhou J, et al. Oncotarget. 2017 Jun 20;8(25):40425-40433. doi: 10.18632/oncotarget.16390. Oncotarget. 2017. PMID: 28415576 Free PMC article.

9

The Effect of Histological Subtypes on Outcomes of Stage IV Epithelial Ovarian Cancer.

Zhou J, Wu SG, Wang J, Sun JY, He ZY, Jin X, Zhang WW. Zhou J, et al. Front Oncol. 2018 Dec 4;8:577. doi: 10.3389/fonc.2018.00577. eCollection 2018. Front Oncol. 2018. PMID: 30564556 Free PMC article.

10

KIF11 Functions as an Oncogene and Is Associated with Poor Outcomes from Breast Cancer.

Zhou J, Chen WR, Yang LC, Wang J, Sun JY, Zhang WW, He ZY, Wu SG. Zhou J, et al. Cancer Res Treat. 2019 Jul;51(3):1207-1221. doi: 10.4143/crt.2018.460. Epub 2018 Dec 27. Cancer Res Treat. 2019. PMID: 30590004 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54,278 results

Search Page

Filters